MERRIMACK PHARMACEUTICALS INChttps://pcaobus.org/form-ap-filings/38698/38698MERRIMACK PHARMACEUTICALS INC386984/10/2019 1:56:08 PM20186c6fd25d-13fa-4d36-86dd-86152e3b8628238PricewaterhouseCoopers LLP262379MERRIMACK PHARMACEUTICALS INC1274792MACK0023800611Mark Stephen Barsanti0023800611True
Solid Biosciences Inc.https://pcaobus.org/form-ap-filings/36978/36978Solid Biosciences Inc.369783/27/2019 8:12:07 AM2018e0bea847-dc95-43ea-ae38-75cea1960bc4238PricewaterhouseCoopers LLP699644Solid Biosciences Inc.1707502SLDB0023800611Mark Stephen Barsanti0023800611True
Surface Oncology, Inc.https://pcaobus.org/form-ap-filings/36855/36855Surface Oncology, Inc.368553/26/2019 3:40:58 PM201874eb3322-5564-4f30-9f4d-e1c69f6ccfcd238PricewaterhouseCoopers LLP705429Surface Oncology, Inc.1718108SURF0023800611Mark Stephen Barsanti0023800611True
OCULAR THERAPEUTIX, INChttps://pcaobus.org/form-ap-filings/36821/36821OCULAR THERAPEUTIX, INC368213/26/2019 3:38:10 PM2018dcb2c340-6252-4c31-8be4-57c59789cdcc238PricewaterhouseCoopers LLP381643OCULAR THERAPEUTIX, INC1393434OCUL0023800611Mark Stephen Barsanti0023800611True
Seres Therapeutics, Inc.https://pcaobus.org/form-ap-filings/36831/36831Seres Therapeutics, Inc.368313/26/2019 3:38:10 PM20184257bd01-c700-49b0-a87d-31ee2ef6b07d238PricewaterhouseCoopers LLP589716Seres Therapeutics, Inc.1609809MCRB0023800611Mark Stephen Barsanti0023800611True
Solid Biosciences Inc.https://pcaobus.org/form-ap-filings/22529/22529Solid Biosciences Inc.225294/16/2018 9:29:07 AM2017bb921e7e-b314-4dde-a7ea-dc8f7e35ba83238PricewaterhouseCoopers LLP699644Solid Biosciences Inc.1707502SLDB0023800611Mark Stephen Barsanti0023800611True
Surface Oncology, Inc.https://pcaobus.org/form-ap-filings/22532/22532Surface Oncology, Inc.225324/16/2018 9:29:07 AM201774264d39-4900-496f-ab01-e2bb7aecf9e4238PricewaterhouseCoopers LLP705429Surface Oncology, Inc.1718108SURF0023800611Mark Stephen Barsanti0023800611True
Seres Therapeutics, Inc.https://pcaobus.org/form-ap-filings/20948/20948Seres Therapeutics, Inc.209483/29/2018 6:42:15 PM2017c19d34b4-6d99-4e5b-8cb7-0b0423ba1949238PricewaterhouseCoopers LLP589716Seres Therapeutics, Inc.1609809MCRB0023800611Mark Stephen Barsanti0023800611True
MERRIMACK PHARMACEUTICALS INChttps://pcaobus.org/form-ap-filings/20741/20741MERRIMACK PHARMACEUTICALS INC207413/28/2018 11:06:39 AM20170ac4c244-9a6e-4a9e-b0ae-1bc692bd5290238PricewaterhouseCoopers LLP262379MERRIMACK PHARMACEUTICALS INC1274792MACK0023800611Mark Stephen Barsanti0023800611True
OCULAR THERAPEUTIX, INChttps://pcaobus.org/form-ap-filings/20746/20746OCULAR THERAPEUTIX, INC207463/28/2018 11:06:39 AM2017c4df3d40-d4e5-4112-97de-8ec26ad11e6c238PricewaterhouseCoopers LLP381643OCULAR THERAPEUTIX, INC1393434OCUL0023800611Mark Stephen Barsanti0023800611True